Skip to main content
. Author manuscript; available in PMC: 2012 Jan 14.
Published in final edited form as: AIDS. 2011 Jan 14;25(2):143–152. doi: 10.1097/QAD.0b013e328340fdaf

Table 1.

Patient clinical characteristics for samples used in this study.

Patienta Timepointb CD4c Viral Loadd

plasma BML BMR
1IUT Delivery 94 375,319
1 month 637 1,538
2 months 57,162
4 months 7,845 3,865
9 months 4,454 4,966
12 months 49,333
2IUT Delivery 118 211,792
1 month 20,207 18,277
4 months 83,274 257
12 months 108,722 9,908 6,275
3BM Delivery 134 21,148
1 week NAe NA
1 month 159,012 80,925
4 months 235,196 3,987 10,570
12 months 152,500 NA
4BM Delivery 82 94,873
1 month 18,645
4 months 437,545 1,294 1,882
12 months 115,517 8,468 NA
5BM Delivery 196
1 month 102,438 57,316 59,261
4 months 28,980 15,837
12 months 108,255 7,677 16,087
6IUT Delivery 291 47,602
1 month 22,882 18,863
4 months 38,083 4,767 11,967
12 months 149,262 13,463 51,959
a

BM = breast milk transmitter, IUT = in utero transmitter

b

Times refer to sampling time (months post-delivery) at which samples were collected

c

CD4+ cell counts were measured at delivery for each patient

d

Viralload data from available samples used in this study; BML = left breast milk; BMR = right breast milk

e

NA = viral load was unavailable although sequences were generated and analyzed in this study